Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 16:00:02 2024-06-28 EDT			5-day change	1st Jan Change
233.7 ^USD	+1.20%		-1.92%	-4.15%

06-26	BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool	CI
06-20	Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024	CI

Becton, Dickinson and Company Declares Quarterly Dividend, Payable on March 31, 2017

January 23, 2017 at 04:30 pm

The Board of Directors of BD (Becton, Dickinson and Company) has declared a quarterly dividend of 0.73 cents per common share. The dividend will be payable on March 23, 2017 to holders of record on March 10, 2017.

Latest news about Becton, Dickinson and Company

BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool	06-26	CI
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024	06-20	CI
Evercore ISI Raises Becton, Dickinson and Company's Price Target to $290 From $282	06-14	MT
Sector Update: Health Care Stocks Steady Premarket Monday	06-03	MT
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash	06-03	DJ
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	06-03	MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	06-03	RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	06-03	MT
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	06-02	CI
DBS Bank Adjusts Price Target on Becton, Dickinson to $285 From $300	05-15	MT
Transcript : Becton, Dickinson and Company Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM	05-14
Exclusive-Biden to put tariffs on China medical supplies - sources	05-10	RE
Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating	05-06	MT
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271	05-03	MT
Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280	05-02	MT
Sector Update: Health Care Stocks Mixed Premarket Thursday	05-02	MT
Sector Update: Health Care	05-02	MT
Transcript : Becton, Dickinson and Company, Q2 2024 Earnings Call, May 02, 2024	05-02
Becton, Dickinson's Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised	05-02	MT
Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings	05-02	DJ
(BDX) BD (BECTON DICKINSON AND COMPANY) Expects Fiscal Year 2024 EPS Range $12.95 - $13.15	05-02	MT
Earnings Flash (BDX) BD (BECTON DICKINSON AND COMPANY) Reports Q2 Revenue $5.05B, vs. Street Est of $5.04B	05-02	MT
Earnings Flash (BDX) BD (BECTON DICKINSON AND COMPANY) Posts Q2 EPS $3.17, vs. Street Est of $2.97	05-02	MT
Becton, Dickinson and Company Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-02	CI
Becton, Dickinson and Company Revises Earnings Guidance for the Fiscal Year 2024	05-02	CI

Chart Becton, Dickinson and Company

Duration

Period

More charts

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-31 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Becton, Dickinson and Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

233.7 USD

Average target price

279.2 USD

Spread / Average Target

+19.46%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BECTON, DICKINSON AND COMPANY	-4.15%	67.54B
ABBOTT LABORATORIES	-5.60%	181B
MEDTRONIC PLC	-4.45%	101B
DEXCOM, INC.	-8.63%	45.09B
CENCORA, INC.	+9.70%	44.37B
HOYA CORPORATION	+6.13%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.22%	29.85B
TERUMO CORPORATION	+14.80%	24.49B
WEST PHARMACEUTICAL SERVICES, INC.	-6.46%	23.99B
ZIMMER BIOMET HOLDINGS, INC.	-10.82%	22.33B

Other Medical Equipment, Supplies & Distribution